UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Novel antibodies as anticancer agents

Oncogene, 2007-05, Vol.26 (25), p.3714-3733

2007

Volltextzugriff (PDF)

Critical Role for CD8 in Binding of MHC Tetramers to TCR: CD8 Antibodies Block Specific Binding of Human Tumor- Specific MHC-Peptide Tetramers to TCR

The Journal of immunology (1950), 2001-07, Vol.167 (1), p.270-276

2001

Volltextzugriff (PDF)

Modifying interleukin-2 concentrations during culture improves function of T cells for adoptive immunotherapy

Cytotherapy (Oxford, England), 2009-01, Vol.11 (2), p.206-217

2009

Volltextzugriff (PDF)

Antibody engineering of recombinant Fv immunotoxins for improved targeting of cancer: disulfide-stabilized Fv immunotoxins

Clinical cancer research, 1996-02, Vol.2 (2), p.245-252

1996

Volltextzugriff (PDF)

A Recombinant Immunotoxin Containing a Disulfide-Stabilized Fv Fragment

Proceedings of the National Academy of Sciences - PNAS, 1993-08, Vol.90 (16), p.7538-7542

1993

Volltextzugriff (PDF)

Sublytic complement attack protects tumor cells from lytic doses of antibody and complement

European journal of immunology, 1992-05, Vol.22 (5), p.1207-1213

1992

Volltextzugriff (PDF)

Improved binding and antitumor activity of a recombinant anti-erbB2 immunotoxin by disulfide stabilization of the Fv fragment

The Journal of biological chemistry, 1994-07, Vol.269 (28), p.18327-18331

1994

Volltextzugriff (PDF)

Complement membrane attack complex, perforin, and bacterial exotoxins induce in K562 cells calcium-dependent cross-protection from lysis

The Journal of immunology (1950), 1995-08, Vol.155 (4), p.2203-2210

1995

Volltextzugriff (PDF)

The influence of a human embryonic stem cell-derived microenvironment on targeting of human solid tumor xenografts

Cancer research (Chicago, Ill.), 2006-04, Vol.66 (7), p.3792-3801

2006

Volltextzugriff (PDF)

Antibodies and their fragments as anti-cancer agents

Current pharmaceutical design, 2006, Vol.12 (3), p.363-378

2006

Volltextzugriff (PDF)

Recombinant immunotoxins in targeted cancer cell therapy

Advances in Cancer Research, 2001, Vol.81, p.93-124

Reiter, Yoram

2001

Volltextzugriff (PDF)

Recombinant Fv immunotoxins and Fv fragments as novel agents for cancer therapy and diagnosis

Trends in Biotechnology, 1998-12, Vol.16 (12), p.513-520

1998

Volltextzugriff (PDF)

The Palestinian-Transjordanian Rift: Economic Might and Political Power in Jordan

The Middle East journal, 2004, Vol.58 (1), p.72-92

Reiter, Yitzhak

2004

Volltextzugriff (PDF)

Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A201 complexes on CD4+ CD25+ T Cells detected by peptide-specific, major histocompatibility complex-restricted antibodies in patients with HTLV-I-associated neurologic disease

The Journal of experimental medicine, 2004-05, Vol.199 (10), p.1367-1377

2004

Volltextzugriff (PDF)

Modification of a Tumor-Derived Peptide at an HLA-A2 Anchor Residue Can Alter the Conformation of the MHC-Peptide Complex: Probing with TCR-Like Recombinant Antibodies

The Journal of immunology (1950), 2002-10, Vol.169 (8), p.4399-4407

2002

Volltextzugriff (PDF)

Novel antibodies as anticancer agents: Antibody therapies for cancer

Oncogene, 2007, Vol.26 (25), p.3714-3733

2007

Volltextzugriff (PDF)

Direct Visualization of Distinct T Cell Epitopes Derived from a Melanoma Tumor-Associated Antigen by Using Human Recombinant Antibodies with MHC-Restricted T Cell Receptor-like Specificity

Proceedings of the National Academy of Sciences - PNAS, 2002-07, Vol.99 (14), p.9421-9426

2002

Volltextzugriff (PDF)

Selective Targeting of Melanoma and APCs Using a Recombinant Antibody with TCR-Like Specificity Directed Toward a Melanoma Differentiation Antigen

The Journal of immunology (1950), 2003-09, Vol.171 (5), p.2197-2207

2003

Volltextzugriff (PDF)

Direct Phenotypic Analysis of Human MHC Class I Antigen Presentation: Visualization, Quantitation, and In Situ Detection of Human Viral Epitopes Using Peptide-Specific, MHC-Restricted Human Recombinant Antibodies

The Journal of immunology (1950), 2003-04, Vol.170 (8), p.4349-4361

2003

Volltextzugriff (PDF)

Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit

Cancer research (Chicago, Ill.), 2002-06, Vol.62 (11), p.3184-3194

2002

Volltextzugriff (PDF)

Dissecting cytotoxic T cell responses towards the NY‐ESO‐1 protein by peptide/MHC‐specific antibody fragments

European journal of immunology, 2004-10, Vol.34 (10), p.2919-2929

2004

Volltextzugriff (PDF)

Extended presentation of specific MHC‐peptide complexes by mature dendritic cells compared to other types of antigen‐presenting cells

European journal of immunology, 2004-06, Vol.34 (6), p.1551-1560

2004

Volltextzugriff (PDF)

Targeting of complement to tumor cells by heteroconjugates composed of antibodies and of the complement component C3b

The Journal of immunology (1950), 1989-04, Vol.142 (8), p.2771-2777

1989

Volltextzugriff (PDF)

Human CTLs to wild-type and enhanced epitopes of a novel prostate and breast tumor-associated protein, TARP, lyse human breast cancer cells

Cancer research (Chicago, Ill.), 2004-04, Vol.64 (7), p.2610-2618

2004

Volltextzugriff (PDF)

Tumor-Specific Ab-Mediated Targeting of MHC-Peptide Complexes Induces Regression of Human Tumor Xenografts in Vivo

Proceedings of the National Academy of Sciences - PNAS, 2004-06, Vol.101 (24), p.9051-9056

2004

Volltextzugriff (PDF)

1 – 25 von 971

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(837)
Mit Volltextzugriff
(721)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Novel antibodies as anticancer agents

Critical Role for CD8 in Binding of MHC Tetramers to TCR: CD8 Antibodies Block Specific Binding of Human Tumor- Specific MHC-Peptide Tetramers to TCR

Modifying interleukin-2 concentrations during culture improves function of T cells for adoptive immunotherapy

Antibody engineering of recombinant Fv immunotoxins for improved targeting of cancer: disulfide-stabilized Fv immunotoxins

A Recombinant Immunotoxin Containing a Disulfide-Stabilized Fv Fragment

Sublytic complement attack protects tumor cells from lytic doses of antibody and complement

Improved binding and antitumor activity of a recombinant anti-erbB2 immunotoxin by disulfide stabilization of the Fv fragment

Complement membrane attack complex, perforin, and bacterial exotoxins induce in K562 cells calcium-dependent cross-protection from lysis

The influence of a human embryonic stem cell-derived microenvironment on targeting of human solid tumor xenografts

Antibodies and their fragments as anti-cancer agents

Recombinant immunotoxins in targeted cancer cell therapy

Recombinant Fv immunotoxins and Fv fragments as novel agents for cancer therapy and diagnosis

The Palestinian-Transjordanian Rift: Economic Might and Political Power in Jordan

Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A201 complexes on CD4+ CD25+ T Cells detected by peptide-specific, major histocompatibility complex-restricted antibodies in patients with HTLV-I-associated neurologic disease

Modification of a Tumor-Derived Peptide at an HLA-A2 Anchor Residue Can Alter the Conformation of the MHC-Peptide Complex: Probing with TCR-Like Recombinant Antibodies

Novel antibodies as anticancer agents: Antibody therapies for cancer

Direct Visualization of Distinct T Cell Epitopes Derived from a Melanoma Tumor-Associated Antigen by Using Human Recombinant Antibodies with MHC-Restricted T Cell Receptor-like Specificity

Selective Targeting of Melanoma and APCs Using a Recombinant Antibody with TCR-Like Specificity Directed Toward a Melanoma Differentiation Antigen

Direct Phenotypic Analysis of Human MHC Class I Antigen Presentation: Visualization, Quantitation, and In Situ Detection of Human Viral Epitopes Using Peptide-Specific, MHC-Restricted Human Recombinant Antibodies

Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit

Dissecting cytotoxic T cell responses towards the NY‐ESO‐1 protein by peptide/MHC‐specific antibody fragments

Extended presentation of specific MHC‐peptide complexes by mature dendritic cells compared to other types of antigen‐presenting cells

Targeting of complement to tumor cells by heteroconjugates composed of antibodies and of the complement component C3b

Human CTLs to wild-type and enhanced epitopes of a novel prostate and breast tumor-associated protein, TARP, lyse human breast cancer cells

Tumor-Specific Ab-Mediated Targeting of MHC-Peptide Complexes Induces Regression of Human Tumor Xenografts in Vivo

Suchergebnisse filtern